Psychiatry Research
Volume 109, Issue 2 , Pages 143-148 , 15 March 2002

Decreased serum brain-derived neurotrophic factor levels in major depressed patients

  • Félicien Karege

      Affiliations

    • Laboratory of Biochemistry, Division of Neuropsychiatry, Geneva University Hospitals, 2 chemin du Petit Bel-Air, CH-1225 Chêne-Bourg, Geneva, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41-22-3055314; fax: +41-22-3055309
    • ,
  • Guillaume Perret

      Affiliations

    • Department of Psychiatry, 2 chemin du Petit Bel-Air, CH-1225 Chêne-Bourg, Geneva, Switzerland
    • ,
  • Guido Bondolfi

      Affiliations

    • Department of Psychiatry, 2 chemin du Petit Bel-Air, CH-1225 Chêne-Bourg, Geneva, Switzerland
    • ,
  • Michèle Schwald

      Affiliations

    • Laboratory of Biochemistry, Division of Neuropsychiatry, Geneva University Hospitals, 2 chemin du Petit Bel-Air, CH-1225 Chêne-Bourg, Geneva, Switzerland
    • ,
  • Gilles Bertschy

      Affiliations

    • Department of Psychiatry, 2 chemin du Petit Bel-Air, CH-1225 Chêne-Bourg, Geneva, Switzerland
    • ,
  • Jean-Michel Aubry

      Affiliations

    • Department of Psychiatry, 2 chemin du Petit Bel-Air, CH-1225 Chêne-Bourg, Geneva, Switzerland

Received 22 August 2001 ,Revised 2 January 2002 ,Accepted 14 January 2002.

References 

  1. Altar CA. Neurotrophins and depression. Trends in Pharmacological Sciences. 1999;20:59–61
  2. Angelucci F, Aloe L, Vasquez PJ, Mathé AA. Mapping the differences in the brain concentration of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in animal model of depression. Neuroreport. 2000;11:1369–1373
  3. Apfel SC. Clinical Applications of Neurotrophic Factors. Philadelphia, PA: Lippincott–Raven Press; 1997;
  4. Bersani G, Iannitelli A, Maselli P, Pancheri P, Aloe L, Angelucci F, et al. Low nerve growth factor plasma levels in schizophrenic patients: a preliminary study. Schizophrenia Research. 1999;37:201–203
  5. Bremer JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. American Journal of Psychiatry. 2000;157:115–118
  6. Chen B, Dowlatshahi D, MacQueen GM, Wang J-F, Young LT. Increased hippocampal BDNF immunoreactivity in subjects treated with anti-depressant medication. Biological Psychiatry. 2001;50:260–265
  7. Connor B, Young D, Yan Q, Faull RLM, Synek B, Dragunow M. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Molecular Brain Research. 1997;49:71–81
  8. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Archives of General Psychiatry. 1997;54:597–605
  9. Durany N, Michel T, Kurt J, Cruz-Sanchez FF, Cervas-Navarro J, Riederer P. Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains. International Journal of Developmental Neuroscience. 2000;18:807–813
  10. Hrdina PD, Bakish D, Chudzik J, Ravindram A, Lapierre YD. Serotoninergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors. Journal of Psychiatric Neuroscience. 1995;20:11–19
  11. Kitiyama I, Yaga T, Kayahara T, Katsuma N, Murase S, Otani M, et al. Long-term stress degenerates, but imipramine regenerates, noradrenergic axons in the rat cerebral cortex. Biological Psychiatry. 1997;42:687–696
  12. Lewin GR, Barde YA. Physiology of neurotrophins. Annual Review of Neuroscience. 1996;19:289–317
  13. Lindsay RM, Wiegrand SJ, Altar CA, Di Stefano S. Neurotrophic factors: from molecule to man. Trends in Neuroscience. 1994;17:182–189
  14. Mamounas LA, Blue ME, Siuciak JA, Altar CA. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. Journal of Neuroscience. 1995;15:7929–7939
  15. Mann JJ, McBride PA, Anderson GM, Mieczkowski TA. Platelet and whole blood serotonin content in depressed inpatients: correlations with acute and life-time psychopathology. Biological Psychiatry. 1992;32:243–257
  16. Montgomery SA, Asberg MA. A new depression scale designed to be sensitive to change. British Journal of Psychiatry. 1979;134:382–389
  17. Nemeroff CB, Knight DL, Franks J, Craighead WE, Krishnan RR. Further studies on platelet serotonin transporter binding in depression. American Journal of Psychiatry. 1994;151:1623–1625
  18. Nibuya M, Morinabu S, Duman S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience. 1995;15:7539–7547
  19. Okazawa H, Muarata M, Watanabe M, Kanazawa I. Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum. FEBS Letters. 1992;313:138–142
  20. Oliff HS, Bertchtold NC, Isackson P, Cotman CW. Exercise-induced regulation of brain-derived neurotrophic factor (BDNF) transcripts in the rat hippocampus. Brain research. Molecular Brain Research. 1998;61:147–153
  21. Pan W, Banks WA, Fasold MB, Blunth J, Kasten AJ. Transport of brain-derived neurotrophic factor across the blood–brain barrier. Neuropharmacology. 1998;37:1553–1561
  22. Pandey SC, Zhang D, Mittal N, Nayyar D. Potential role of the gene transcription factor cyclic AMP-responsive element binding protein in ethanol withdrawal-related anxiety. Journal of Experimental and Therapeutics. 1999;288:866–878
  23. Pearse HGE. The APUD concept and hormone production. Clinical Endocrinology and Metabolism. 1980;9:211–222
  24. Radka SF, Holst PA, Fristche M, Altar CA. Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Research. 1996;709:122–130
  25. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biological Psychiatry. 2000;48:766–777
  26. Rajkowska G, Michel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, et al. Morphologic evidence for neuronal and glyal prefrontal cell pathology in major depression. Biological Psychiatry. 1999;45:1085–1098
  27. Russo-Neustadt A, Beard C, Cotman CW. Excercise, antidepressant medications, and enhanced brain-derived neurotrophic factor expression. Neuropsychopharmacology. 1999;21:679–682
  28. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MM. Hippocampal atrophy in recurrent major depression. Proceedings of National Academy of Science. 1996;93:3908–3913
  29. Shelton RC. Cellular mechanisms in the vulnerability to depression response to antidepressants. The Psychiatric Clinics of North America. 2000;23:713–729
  30. Siuciak JA, Lewis D, Wiegand SJ. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacological and Biochemical Behavior. 1997;56:131–137
  31. Takahashi M, Shirakawa O, Toyooka K, Kitamura N, Hashimoto T, Maeda K, et al. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Molecular Psychiatry. 2000;5:293–300
  32. Watanabe Y, Gould E, Daniels DC, Cameron H, McEwen BS. Tianeptine attenuates stress-induced morphological changes in the hippocampus. European Journal of Pharmacology. 1992;222:157–162
  33. Yamamoto H, Gurney ME. Human platelets contain brain-derived neurotrophic factor. Journal of Neuroscience. 1990;10:3469–3478

PII: S0165-1781(02)00005-7

Psychiatry Research
Volume 109, Issue 2 , Pages 143-148 , 15 March 2002

Article Tools

* Image Usage & Resolution